SAGE - Sage Therapeutics, Inc.
8.68
-0.020 -0.230%
Share volume: 22,698,684
Last Updated: 07-30-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$8.70
-0.02
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | |
| Report Date | 04-25-2024 | 07-31-2024 | 10-29-2024 | 02-11-2025 | 04-29-2025 | 07-30-2025 | |
| Total revenue | 7.902 M | 8.654 M | 11.871 M | 12.816 M | 14.063 M | 31.660 M | |
| Cost of revenue | 1.269 M | 1.407 M | 5.278 M | -6.547 M | 0.000 | 0.000 | |
| Gross profit | 6.633 M | 7.247 M | 6.593 M | 19.363 M | 14.063 M | 31.660 M | |
| 9.26% | -9.02% | 193.69% | -27.37% | 125.13% | |||
| Operating expenses | 124.308 M | 118.547 M | 107.795 M | 91.665 M | 80.350 M | 85.914 M | |
| Selling general and admin | 52.574 M | 55.983 M | 53.219 M | 54.644 M | 57.591 M | 61.997 M | |
| Research and development | 71.734 M | 62.564 M | 54.576 M | 37.021 M | 22.759 M | 23.917 M | |
| Total expenses | 125.577 M | 119.954 M | 107.795 M | 121.556 M | 81.518 M | 85.629 M | |
| -4.48% | -10.14% | 12.77% | -32.94% | 5.04% | |||
| Operating income | -117.675 M | -111.300 M | -101.202 M | -102.193 M | -67.455 M | -53.969 M | |
| Ebit | -117.675 M | -111.300 M | -101.202 M | -102.193 M | -67.437 M | -53.975 M | |
| Pretax income | -108.483 M | -102.854 M | -93.560 M | -95.766 M | -62.214 M | -49.652 M | |
| -5.19% | -9.04% | 2.36% | -35.04% | -20.19% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -108.483 M | -102.854 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| 5.19% | 100.00% | ||||||
| Net income | -108.483 M | -102.854 M | -93.551 M | -95.778 M | -62.214 M | -49.652 M | |
| 5.19% | 9.04% | -2.38% | 35.04% | 20.19% |